Arvinas Inc (ARVN)

Nov 03, 2025

Arvinas to present data on BCL6 degrader at ASH annual meeting - Investing.com

Nov 03, 2025

Nov 03, 2025

Arvinas (NASDAQ: ARVN) to present ARV-393 data with glofitamab at ASH on Dec. 6 - Stock Titan

Nov 03, 2025

Nov 03, 2025

Arvinas Inc expected to post a loss of 79 cents a shareEarnings Preview - TradingView

Nov 03, 2025

Nov 03, 2025

Arvinas to Participate in Upcoming Investor Conferences - The Manila Times

Nov 03, 2025

Nov 03, 2025

Can Arvinas Inc. stock beat analyst upgradesMarket Rally & Free Safe Capital Growth Stock Tips - newser.com

Nov 03, 2025

Nov 03, 2025

Historical volatility pattern of Arvinas Inc. visualizedInsider Buying & Low Risk Entry Point Guides - newser.com

Nov 03, 2025

Nov 03, 2025

Is Arvinas Inc. still worth holding after the dipMarket Risk Summary & Daily Market Momentum Tracking - newser.com

Nov 03, 2025

Nov 03, 2025

Is Arvinas Inc. stock affected by interest rate hikesWeekly Trend Report & Breakout Confirmation Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

How Arvinas Inc. stock benefits from strong dollarJuly 2025 Chart Watch & Free Technical Pattern Based Buy Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Has Arvinas Inc. formed a bullish divergenceJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com

Nov 03, 2025

Nov 03, 2025

Will Arvinas Inc. stock outperform tech sector in 2025Insider Buying & Advanced Swing Trade Entry Plans - newser.com

Nov 03, 2025

Nov 02, 2025

How to escape a deep drawdown in Arvinas Inc.July 2025 News Drivers & Fast Entry Momentum Alerts - newser.com

Nov 02, 2025

Nov 01, 2025

Live market analysis of Arvinas Inc.Weekly Trend Recap & Technical Confirmation Alerts - newser.com

Nov 01, 2025

Oct 31, 2025

Order flow analysis tools used on Arvinas Inc.July 2025 Summary & Long-Term Growth Portfolio Plans - newser.com

Oct 31, 2025

Oct 31, 2025

Can technical indicators confirm Arvinas Inc.’s reversalJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com

Oct 31, 2025

Oct 31, 2025

Is Arvinas Inc. stock a top pick in earnings seasonPrice Action & Weekly High Return Forecasts - newser.com

Oct 31, 2025

Oct 30, 2025

BTIG Maintains Buy Rating on Arvinas (ARVN), Raises Price Target to $14.00 | ARVN Stock News - GuruFocus

Oct 30, 2025

Oct 30, 2025

BTIG Maintains Arvinas (ARVN) Buy Recommendation - Nasdaq

Oct 30, 2025

Oct 30, 2025

Arvinas stock price target raised to $14 from $10 at BTIG on KRASG12D degrader potential - Investing.com

Oct 30, 2025

Oct 30, 2025

Arvinas Inc. stock chart pattern explainedEarnings Risk Report & Expert Approved Trade Ideas - newser.com

Oct 30, 2025

Oct 30, 2025

Published on: 2025-10-30 00:10:42 - newser.com

Oct 30, 2025

Oct 29, 2025

Arvinas to Report Third Quarter 2025 Financial Results on November 5, 2025 - The Manila Times

Oct 29, 2025

Oct 29, 2025

Arvinas (NASDAQ: ARVN) sets Nov. 5 webcast to review Q3 2025 results - Stock Titan

Oct 29, 2025

Oct 28, 2025

Why Arvinas Inc. stock appeals to analystsJuly 2025 Breakouts & AI Driven Price Forecasts - fcp.pa.gov.br

Oct 28, 2025

Oct 28, 2025

Why Arvinas Inc. stock is a must watch in 2025Market Activity Summary & Precise Trade Entry Recommendations - Fundação Cultural do Pará

Oct 28, 2025

Oct 28, 2025

Arvinas Plunges 45% After Pfizer-Partnered Drug Disappoints - MSN

Oct 28, 2025

Oct 27, 2025

Can Arvinas Inc. stock hit analyst price targetsEarnings Summary Report & Fast Moving Stock Trade Plans - fcp.pa.gov.br

Oct 27, 2025